Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 29;20(1):621.
doi: 10.3390/ijerph20010621.

Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts

Dawit Getachew Assefa  1   2 , Eden Dagnachew Zeleke  1   3 , Delayehu Bekele  1   4 , Dawit A Ejigu  5 , Wondwosen Molla  6 , Tigist Tekle Woldesenbet  7 , Amdehiwot Aynalem  8 , Mesfin Abebe  6 , Andualem Mebratu  6 , Tsegahun Manyazewal  1
Affiliations

Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts

Dawit Getachew Assefa et al. Int J Environ Res Public Health. .

Abstract

Background: Tuberculosis (TB) is a major cause of morbidity and mortality in people living with HIV (PLWHIV). Isoniazid preventive therapy (IPT) prevents TB in PLWHIV, but estimates of its effects and actual implementation vary across countries. We reviewed studies that examined the impact of IPT on PLHIV and the factors influencing its implementation in Ethiopia.

Methods: We searched PubMed/MEDLINE, Embase, and the Cochrane Central Register of Clinical Controlled Trials from their inception to 1 April 2021 for studies of any design that examined the impact of IPT on PLHIV and the factors influencing its implementation. The protocol was registered in PROSPERO, ID: CRD42021256579.

Result: Of the initial 546 studies identified, 13 of which enrolled 12,426 participants, 15,640 PLHIV and 62 HIV clinical care providers were included. PLHIV who were on IPT, independently or simultaneously with ART, were less likely to develop TB than those without IPT. IPT interventions had a significant association with improved CD4 count and reduced all-cause mortality. IPT was less effective in people with advanced HIV infection. The major factors influencing IPT implementation and uptake were stock-outs, fear of developing isoniazid-resistant TB, patient's refusal and non-adherence, and improper counseling and low commitment of HIV clinical care providers.

Conclusion: IPT alone or in combination with ART significantly reduces the incidence of TB and mortality in PLHIV in Ethiopia than those without IPT. More research on safety is needed, especially on women with HIV who receive a combination of IPT and ART. Additionally, studies need to be conducted to investigate the efficacy and safety of the new TPT (3 months combination of isoniazid and rifapentine) in children and people living with HIV.

Keywords: Ethiopia; HIV; antiretroviral therapy (ART); isoniazid prevention therapy (IPT); tuberculosis.

PubMed Disclaimer

Conflict of interest statement

We declare that they have no competing interest.

Figures

Figure 1
Figure 1
PRISMA study flow diagram.
See this image and copyright information in PMC

References

    1. Global Tuberculosis Report 2022. World Health Organization; Geneva, Switzerland: 2022. [(accessed on 10 November 2022)]. Available online: http://apps.who.int/iris.
    1. Global Tuberculosis Report 2018. World Health Organization; Geneva, Switzerland: 2018. [(accessed on 10 November 2022)]. Available online: http://apps.who.int/iris.
    1. Ethiopia National Strategic Plan Tuberculosis and Leprosy Control 2013–2020. Addis Ababa: Federal Democratic Republic of Ethiopia Ministry of Health. 2017. 2017. [(accessed on 16 February 2022)]. Available online: https://www.afro.who.int/sites/default/files/2019-04/Ethiopia%20-%20Nati....
    1. WHO . Isoniazid Preventive Terapy (IPT) and TB Infection Control (IC) for People Living with HIV, Report of a JointWorld Health Organization HIV/Aids and TB Department Meeting. WHO; Geneva, Switzerland: 2008. [(accessed on 12 December 2021)]. Three I’s Meeting Intensified Case Finding (ICF) Available online: http://apps.who.int/iris.
    1. WHO . Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes. Volume 7. World Health Organization; Geneva, Switzerland: 2008. [(accessed on 12 December 2021)]. Isoniazid Preventive Therapy. Available online: https://www.ncbi.nlm.nih.gov/books/NBK310749/ - PubMed

Publication types